l' re; uni;ersity of Berlin, Germany. The anaemias o f prematurity are characlerizcd by inadequate crytliropoietin response and require freyuent ~ransfusions. hlell~ods: I n a 12 centre 1)lindcd ~ri;ll, V L B W infants wcre ran omlzed ~n t r~ rhEPO ( n = 120) or control group ( n = 121) on dn 3 of lifc. Blindin wa\ emured by two indcpcnderi~ tc;ima In cacli centre. r l i~~g was givcn 3 x 2.51 llJ,kgjweek s.c. from tI:~y 3 to dav 42 of life (17 single doses). Oral Iron rtartcd in both groups on day 14 w~t l~ 2 In ')da and waa ;~djustcd :~ccording to serum fcrritin levels. Results: I<cliculocytc (~~f ; l n J l i c u t r o~,~l i~ counta (x10"/1) : 1989;139:682-87) . Little is known about lung hyaluronan contcrlt in the perinatal period. I n rabbit pups lung hyaluronan concentration decreases just before term and lung water decreases at term (Am J Physiol 1991;260:H1449-54). Data on prererm rabbits have been presented previously (Ped Res 1992;32:635. The present study was undertaken to study the effect of oxygen exposure on lung hyaluronan concentration and lung water in rabbit pups born at term. Some pups were kcpt in oxygen and some wcre kcpt in air. I'ups were sacrificed and lungs were tnkcn at an age of 4-6 days. Tllc walcr coritenl was ~iiwsurcd as welldry wc~ghl, and Ihe l~yaluronan conccntration witli a r;~d~olilctric assny kit ( [ [ A 50, I'har~~incla, Illlpbnl;~). Rcsulls: In the lungs from pups kept in oxygen significantly liigl~cr hyaluronan concentrations werc sccn both at 4 (p<O.lXIl;n= 14) arid 6 (p<O.Ol;n= 17) d;~ys o f age compared to the lungs from the pups kcpt in air (n=15 and 29, rcspcc~ively). This was accompanied by a higher lung water conlcnt (p<0.001) than in pups kept in air al 4 dnys o f age. Conclusion: I n tcrlii rabbit pups lung I~y;\luron;ln co~iccritr;tt~on ;~nd lulig \v.ltcr conlent IncrcJsc during oxygcn expolure.
PERSISTENT PULMONARY IIYPERTCNSION OF TllE NEWBORN (PPHN) I S SELECTIVELY LOWERED DY PROSTACYCLIN ( P C ) . , M a r i a n m E r o n e n . M a l i a P o h i a v u o r i . E r k k l P e s o n e n . S t u r e A n d e r s s o n . K a r i 0 . R a i v i p . C h i l d r e n ' s H o s p i t a l a n d D e p a r tm e n t o f ObIGvn. U n i v e r s i t v o f H e l s i n k i . F i n l a n d .
PPHN'~; d common i n d i c a t i o n f o r ECMO b e c a u s e o f s e v e r e h y p o x e m i a a n d m o r t a l i t y r i s k . We s t u d i e d t h e e f f e c t s o f PC
i n 0 i n f a n t s ( b . w t . 2 5 4 0 -4 1 3 0 g, g e s t . a g e 34-42 wk) w i t h r e s p i r a t o r y f a i l u r e a n d PPHN. A t mean a g e 19 ( r a n g e 3 -3 2 ) h , d e s p i t e m a x i m a l v e n t i l a t o r t h e r a p y a n d F i o Z o f 1 . 0 , mcan pa02JPA02 was 0.07 ( r a n g e 0 . 0 4 -0 . 1 0 ) a n d AaD02 614 ( 5 2 1 -6 4 0 
a t w h i c h t i m e PAP h a d d e c r e a s e d t o 49
( 4 5 -5 5 ) a n d DP t o 53 ( 4 2 -6 3 ) mmllg, PAP t h e r e a f t e r r e m a i n i n g b e l o w BP. A f t e r 7 2 h PAP was 50 ( 2 5 -8 6 ) , BP 6 6 (55-72), paOZJPA02 0.14 (0.08-0,40), a n d AaDO2 429 ( 8 3 -6 0 5 ) a t F i 0 2 o f 0 . 5 9 . A l l p a t i e n t s s u r v i v e d w i t h o u t ECMO, PC was s t o p p e d a t 5 . 3 ( 3 -1 0 . 5 ) d a n d v e n t i l a t o r t h e r a p y a t 7 . The effect of surfactants In lreatment of neonalal RDS IS well known However, the favourable results Increase the demand for neonalal lnteslve care We collected retrospectively cllnlcal and follow-up data of all 29 very low blrthwe~ght (VLBW) Infants who recelved surfactant In the OSlRlS study (from March 1991 to November 1991) and of 30 VLBW patlents born durtng the prevlous year who d~d not recelve surfactant treatment Pallenls were el~glble lo the control group 11 they had at least once arter~al/alveolar oxygen ratlo <O 22
The geslatlonal age, b~rthwe~ght and blood pressure were slmllar In both groups Only 6 Infants In the control group survived and only 2 of lhern d~d no1 have any neurologlcal sequelae In the OSlRlS group 20 survived 9 wllhout neurologlcal compl~callons The mean duratlon of neonatal lntenslve care was 10 2 days In the controll group and 26 8 days In the OSlRlS group The mean duratlon of neonatal lntenslve care of the survivors was 32 days In bolh groups A slrnllar effect was observed on the tlme on respirator, and on the durabon of oxygen therapy and of hosp~tal care
The costs of neonalal lntenslve care were In 1992 about 1500 US$ and the cost for care on a paedlatrlc ward were about 400 US$ per day Thus glvlng a VLBW Infant surfactant will Increase the costs wlth a1 least 36 000 US$ The costs per survlvor were w~thout surfaclant about 3110 US$ and wlth surfactant 2730 US$ The costs per healthy survlvor were 9330 US$ and 6670 US$, respect~vely Thls study Illustrates the economical problems associated wtth lmprovments of neonatal lntenslve care Although the prlce per survivor decreases the Increase of total costs IS very larqe The prlce of surfactant ltself IS almost neollaible
